- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02162186
Clinical and Radiographic Outcomes of the Corin Tri-Fit Total Hip Replacement
July 13, 2020 updated by: Corin
Analysis of Clinical Outcome and Implant Migration of the Cementless Tri-Fit Total Hip Replacement System
The study will evaluate the radiographs (x-rays) of 100 patients with a TriFIT total hip at 2 weeks, 3 months, 6 months, 12 months, and yearly following surgery to see if there has been any movement or wear in the hip stem over the course of the study.
The study will also record clinical data on each patient using various functional tests and questionnaires at the same intervals.
Study Overview
Status
Completed
Detailed Description
The present study will prospectively recruit 100 patients scheduled for elective total hip replacement with Corin's TriFIT Hip System at the Ottawa Hospital - General Campus.
As part of their clinical care, patients routinely undergo a clinical examination and have had radiographs taken at 2 weeks, 3 months, 6 months, 12 months, and yearly following surgery.
Using specialized software, radiographs from each interval will be examined to assess femoral stem migration and joint wear patterns.
Femoral stem migration will be assessed using computer-assisted software.
The study will also assess the rate of implant failure during the first two post-operative years.
Clinical assessments and questionnaires will also be completed during each of the follow-up intervals.
Study Type
Observational
Enrollment (Actual)
37
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Ottawa, Ontario, Canada, K1H 8L6
- Ottawa Hospital - General Campus
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The first 100 patients Dr. Paul Beaule undergoing a total hip replacement with Corin's TriFIT Total Hip replacement system that meet the eligibility requirements and consent to do the study.
Description
Inclusion Criteria:
- Patients scheduled for primary, unilateral total hip replacement (THR) with no previous history of hip replacement and/or fracture surgery.
- Patients with arthritis secondary Noninflammatory Degenerative Joint Diseases (NIDJD), including osteo/degenerative arthritis, congenital hip dysplasia, and avascular necrosis.
- Patients who do not meet any of the exclusion criteria.
Exclusion Criteria:
- Patients with previous fusions, acute femoral neck fractures, above knee amputations, or previous total knee replacement.
- Patients who had previously undergone an ipsilateral hemi resurfacing, total resurfacing, total bipolar, unipolar or total hip replacement device.
- Patients with neuropathic joints.
- Patients who required structural bone grafts.
- Patients with an ipsilateral girdlestone.
- Patients who otherwise met the study criteria, but for which appropriate clinical follow-up data is not available (i.e. patients deceased prior to 2-year follow-up, patients refused to return for follow-up).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Femoral Stem Migration Radiographic Assessment
Time Frame: 2 weeks to end of study (approximately 2 years) post-operatively
|
Femoral stem migration (in millimeters (mm)) will be assessed using computer-assisted Einzel Bild Roentgen Analyze-Femoral Component Analysis (EBRA-FCA) software and radiographs taken at each interval.
|
2 weeks to end of study (approximately 2 years) post-operatively
|
Rate of Implant Failure
Time Frame: 2 weeks to end of study (approximately 2 years) post-operatively
|
The number of revisions will be recorded.
|
2 weeks to end of study (approximately 2 years) post-operatively
|
Radiographic Assessment of Wear in the Acetabular Components
Time Frame: 2 weeks to end of study (approximately 2 years) post-operatively
|
Anterior-posterior (AP) and lateral radiographs from each follow-up visit will be used to assess wear of the acetabular (hip) components.
|
2 weeks to end of study (approximately 2 years) post-operatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Harris Hip Score (HHS)
Time Frame: 2 weeks to end of study (approximately 2 years) post-operatively
|
A standardized set of questions and measurements to assess the function of the hip.
It includes pain, function, range of motion (ROM), and absence of deformity.
|
2 weeks to end of study (approximately 2 years) post-operatively
|
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Time Frame: 2 weeks to end of study (approximately 2 years) post-operatively
|
A standardized set of questions and measurements to assess the function of the hip.
It includes pain, stiffness, and joint function.
|
2 weeks to end of study (approximately 2 years) post-operatively
|
SF (Short Form)-12 Questionnaire
Time Frame: 2 weeks to end of study (approximately 2 years) post-operatively
|
A subject-completed questionnaire with questions and he/she's health and well-being.
|
2 weeks to end of study (approximately 2 years) post-operatively
|
UCLA (University of California, Los Angeles) Activity Level
Time Frame: 2 weeks to end of study (approximately 2 years) post-operatively
|
A subject-completed questionnaire which asks his/her current activity level.
|
2 weeks to end of study (approximately 2 years) post-operatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2014
Primary Completion (Actual)
December 1, 2019
Study Completion (Actual)
December 1, 2019
Study Registration Dates
First Submitted
June 10, 2014
First Submitted That Met QC Criteria
June 10, 2014
First Posted (Estimate)
June 12, 2014
Study Record Updates
Last Update Posted (Actual)
July 14, 2020
Last Update Submitted That Met QC Criteria
July 13, 2020
Last Verified
November 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Wounds and Injuries
- Congenital Abnormalities
- Joint Diseases
- Musculoskeletal Diseases
- Rheumatic Diseases
- Arthritis
- Hip Injuries
- Musculoskeletal Abnormalities
- Joint Dislocations
- Osteoarthritis
- Necrosis
- Hip Dislocation
- Developmental Dysplasia of the Hip
- Hip Dislocation, Congenital
- Osteoarthritis, Hip
Other Study ID Numbers
- CSP2013-12
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Avascular Necrosis
-
The Hospital for Sick ChildrenTerminatedFemoral Head Avascular NecrosisCanada
-
Universidad Autonoma de MadridCompletedAvascular Necrosis of the Femoral HeadItaly, France, Germany, Spain
-
Guangdong Provincial People's HospitalUnknownAvascular Necrosis of Femur Head
-
University Hospital, Basel, SwitzerlandWithdrawnAvascular Necrosis of the Femoral Head
-
R-BioSMG-SNU Boramae Medical CenterCompletedAvascular Necrosis of the Femoral HeadKorea, Republic of
-
Pei-Yuan Lee, MDAeon Biotechnology CorporationUnknownBone Marrow | Avascular Necrosis of FemurTaiwan
-
Zimmer BiometRecruitingOsteoarthritis, Hip | Avascular Necrosis of Hip | Post-traumatic; Arthrosis | Avascular Necrosis of the Femoral HeadUnited States, Denmark, Japan, Netherlands, Norway, Sweden
-
Zimmer BiometCompletedOsteoarthritis | Avascular Necrosis
-
New Lexington ClinicBiomet Orthopedics, LLCUnknownOsteoarthritis | Avascular NecrosisUnited States
-
Seoul National University Bundang HospitalCompleted